Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 950 GBX 4.17% Market Closed
Market Cap: 4.3B GBX
Have any thoughts about
Hikma Pharmaceuticals PLC?
Write Note

EV/EBIT
Enterprise Value to EBIT

151.4
Current
151.7
Median
16.6
Industry
Lower than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
151.4
=
Enterprise Value
74.5B GBX
/
EBIT
617m USD
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
1.3
2-Years Forward
EV/EBIT
1.2
3-Years Forward
EV/EBIT
1.2

See Also

Discover More